Bolcaen, J.; Nair, S.; Driver, C.H.S.; Boshomane, T.M.G.; Ebenhan, T.; Vandevoorde, C.
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals 2021, 14, 626.
https://doi.org/10.3390/ph14070626
AMA Style
Bolcaen J, Nair S, Driver CHS, Boshomane TMG, Ebenhan T, Vandevoorde C.
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals. 2021; 14(7):626.
https://doi.org/10.3390/ph14070626
Chicago/Turabian Style
Bolcaen, Julie, Shankari Nair, Cathryn H. S. Driver, Tebatso M. G. Boshomane, Thomas Ebenhan, and Charlot Vandevoorde.
2021. "Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma" Pharmaceuticals 14, no. 7: 626.
https://doi.org/10.3390/ph14070626
APA Style
Bolcaen, J., Nair, S., Driver, C. H. S., Boshomane, T. M. G., Ebenhan, T., & Vandevoorde, C.
(2021). Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals, 14(7), 626.
https://doi.org/10.3390/ph14070626